Drugs / Selenium
Selenium
Trials 33
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT04005222 | May 2014 → Sep 2016 | — | Beytepe Murat Erdi Eker State Hospital | Completed | No outcome recorded |
| Phase 12 trials | ||||||
| Phase 1 | NCT01212965 | Sep 2010 → Sep 2011 | lymphatic malformation | Medical College of Wisconsin | Terminated | No outcome recorded |
| Phase 1 | NCT00217516 | Mar 2005 → Feb 2008 | prostate cancer | Roswell Park Cancer Institute | Completed | No outcome recorded |
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT01432873 | Jun 2011 → Oct 2012 | chemotherapy-induced oral mucositis | Tehran University of Medical Sciences | Unknown | No outcome recorded |
| Phase 1/2 | NCT00010842 | Sep 1999 → Dec 2004 | multiple sclerosis | National Center for Complementary and Integrative Health (NCCIH) | Completed | No outcome recorded |
| Phase 27 trials · 2 missed | ||||||
| Phase 2 | NCT04869579 | Aug → Nov 2021 | COVID-19 | CHRISTUS Health | Unknown | No outcome recorded |
| Phase 2 | NCT02421887 | Dec 2015 → Jun 2018 | male infertility | Yale University | Completed | Missed primary |
| Phase 2 | NCT01554345 | Jun 2011 → Aug 2012 | acute kidney injury | Tehran University of Medical Sciences | Unknown | No outcome recorded |
| Phase 2 | NCT00844792 | Oct 2008 → Dec 2013 | prostate cancer | University Health Network, Toronto | Completed | No outcome recorded |
| Phase 2 | NCT00744549 | May 2008 → Dec 2013 | prostate cancer | University Health Network, Toronto | Completed | No outcome recorded |
| Phase 2 | NCT00963131 | Dec 2004 → Dec 2008 | central serous chorioretinopathy | Prince of Songkla University | Completed | No outcome recorded |
| Phase 2 | NCT00207844 | Jan 2002 → Jan 2005 | infectious disease with sepsis | Centre Hospitalier de Meaux | Completed | Missed primary |
| Phase 313 trials · 7 missed | ||||||
| Phase 3 | NCT05614349 | Jan 2023 → Apr 2025 overdue | COVID-19 | Unity Health Toronto | Active not recruiting | Missed primary |
| Phase 3 | NCT00875173 | Oct 2008 → Dec 2016 | Chagas disease | Oswaldo Cruz Foundation | Unknown | Missed primary |
| Phase 3 | NCT00706121 | Jun 2008 → Oct 2015 | colorectal cancer, precancerous condition | SWOG Cancer Research Network | Completed | Missed primary |
| Phase 3 | NCT00395161 | Apr 2007 → Nov 2009 | infectious disease with sepsis | Michael Dean | Terminated | Missed primary |
| Phase 3 | NCT00553124 | Dec 2005 → ? | urinary bladder cancer | University Hospital Birmingham | Unknown | No outcome recorded |
| Phase 3 | NCT00553345 | Dec 2005 → ? | urinary bladder cancer | University of Birmingham | Unknown | No outcome recorded |
| Phase 3 | NCT00784225 | Jul 2004 → Nov 2017 | cataract, macular degeneration | SWOG Cancer Research Network | Completed | Missed primary |
| Phase 3 | NCT00515736 | Jan 2003 → Dec 2005 | subarachnoid hemorrhage | Centre Hospitalier Universitaire Vaudois | Terminated | No outcome recorded Stop: Enrollment |
| Phase 3 | NCT00006392 | Jul 2001 → May 2011 | prostate cancer | SWOG Cancer Research Network | Completed | Missed primary |
| Phase 3 | NCT00008385 | Dec 2000 → Jun 2011 | lung cancer | ECOG-ACRIN Cancer Research Group | Completed | Missed primary |
| Phase 3 | NCT00170404 | Jun 2000 → Oct 2005 | tuberculosis | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
| Phase 3 | NCT00339768 | Jul 1995 → Jun 1996 | preneoplastic lesion | National Cancer Institute (NCI) | Completed | Mixed |
| Phase 3 | NCT01437826 | Mar 1988 → Jun 1996 | colorectal adenoma | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | Terminated | No outcome recorded |
| Phase 44 trials | ||||||
| Phase 4 | NCT06362005 | May 2024 → Jul 2025 | lichen planus, oral | Al-Azhar University | Completed | No outcome recorded |
| Phase 4 | NCT00860379 | Jan 2009 → Dec 2019 | — | Shriners Hospitals for Children | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT00186706 | Sep 2005 → Nov 2007 | cardiovascular disorder, chronic obstructive pulmonary disease | St. Joseph's Health Care London | Completed | No outcome recorded |
| Phase 4 | NCT00160901 | Aug 2003 → Dec 2005 | breast cancer | Heidelberg University | Completed | No outcome recorded |
| Phase not applicable4 trials · 1 missed | ||||||
| — | NCT07334197 | Dec 2026 → Dec 2029 expected | peripartum cardiomyopathy | Tanta University | Not yet recruiting | No outcome recorded |
| — | NCT06042738 | Mar → Nov 2021 | male infertility | Ondokuz Mayıs University | Completed | No outcome recorded |
| — | NCT04942769 | Dec 2019 → Jul 2021 | — | Beijing Chao Yang Hospital | Unknown | No outcome recorded |
| — | NCT00378456 | — | trisomy 21 | Institute of Child Health | Completed | Missed primary |
| Comparator or background therapy8 trials | ||||||
| Phase 2 | NCT02058212 Comparator | Mar → Oct 2013 | endometriosis | Cairo University | Completed | No outcome recorded |
| Phase 2/3 | NCT06117436 Comparator | Oct 2023 → Dec 2024 | — | Ain Shams University | Completed | No outcome recorded |
| Phase 2/3 | NCT03476044 Comparator | Jun 2018 → Mar 2020 | — | Assiut University | Completed | No outcome recorded |
| Phase 3 | NCT04080622 Comparator | Oct 2019 → Oct 2023 | chemotherapy-induced oral mucositis, disease related to hematopoietic stem cell transplant | University Hospital, Angers | Completed | No outcome recorded |
| Phase 3 | NCT00078897 Comparator | Jan 2005 → Jan 2014 | adenomatous colon polyp, colorectal cancer, precancerous condition | University of Arizona | Terminated | No outcome recorded |
| Phase 4 | NCT07758335 Comparator | Jul 2025 → Mar 2027 expected | ulcerative colitis | National Hepatology & Tropical Medicine Research Institute | Recruiting | No outcome recorded |
| Phase 4 | NCT05266794 Comparator | Jan → Apr 2019 | end stage renal failure | Ain Shams University | Completed | No outcome recorded |
| — | NCT06413043 Comparator | May 2024 → Aug 2025 | endocrine exophthalmos | All India Institute of Medical Sciences, Bhubaneswar | Unknown | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 43 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | selenium | “food supplement containing 2000 mg L-carnitine, 2000 mg fructose, 932 mg acetyl L-carnitine, 225 mg vitamin C, 115 mg citric acid, 50 mg coenzyme Q10, 14 mg zinc, 115 µg...” NCT06042738 ↗40“Tablet: Vitamin C, 500 mg; Vitamin D3, 1000 IU; Vitamin E, 400 IU; Folic Acid 1000 mcg; Zinc, 20 mg; Selenium 200 mcg; Lycopene, 10 mg; Capsule: Vitamin D3, 1000 IU,...” NCT02421887 ↗ “The second therapeutic arm investigates a combination antioxidant therapy (selenium 300 µg, zinc 40 mg, lycopene 45 mg and vitamin C 1.5 g), administered for 10 days.” PMID 40754325 ↗ Aug 2025 “Twice a day with meals. Lycopene - 20 mg, Vitamin D3 - 200 IU, Selenium - 100 mcg, Green Tea Extract - 75 mg, Vitamin E - 50 IU” NCT00844792 ↗ “daily supplementation with a combination of alpha-tocopherol, vitamin C, and selenium” NCT00339768 ↗ “daily oral medication consisting of selenium (sodium-selenit 100 microg/d)” NCT00160901 ↗ “tablets composed of 200 mcg selenium \[as l-selenomethionine\]” NCT01437826 ↗ “Lycopene, Vitamin D3, Selenium, Green Tea Extract, Vitamin E” NCT00744549 ↗ “selenium 15 mcg” NCT07758335 ↗ “selenium 40 mg” NCT00963131 ↗ |
| Known as | Selenium - Laboratoire Aguettant | “Selenium - Laboratoire Aguettant” NCT00515736 ↗ |
| Known as | sodium selenite | “Patients received, for 10 days, selenium as sodium selenite (4,000 microg on the first day, 1,000 microg/day on the nine following days) or matching placebo using continuous...” PMID 17617901 ↗ 2007 |
| Known as | sodium-selenit | “selenium (sodium-selenit 100 microg/d)” NCT00160901 ↗ |
| Modality | Other / unclassified | “combination of AOX micronutrient supplements” NCT00515736 ↗ |
| Route | Oral | “Oral selenium (200 microg/d from L-selenomethionine)” PMID 19066370 ↗ Dec 2008 |